| AEA | anandamide |
| 2-AG | 2-arachidonoylglycerol |
| AKT | protein kinase B |
| Ang II | angiotensin II |
| AT1R | type 1 angiotensin receptor |
| BMI | body mass index |
| CB | cannabinoid |
| CB1R | type 1 cannabinoid receptor |
| CB2R | type 2 cannabinoid receptor |
| CB1R-KO | type 1 cannabinoid receptor knockout (CB1R −/−) |
| CCK | cholecystokinin |
| CNS | central nervous system |
| CVD | cardiovascular disease |
| DAG | diacylglycerol |
| DAGL | diacylglycerol lipase |
| eCB | endocannabinoid |
| ECS | endocannabinoid system |
| FAAH | fatty acid amide hydrolase |
| GLUT2 | glucose transporter 2 |
| GPCR | G-protein-coupled receptor |
| HDL | high-density lipoprotein |
| HFD | high-fat diet |
| IR | insulin resistance |
| KO | knockout |
| LDL | low-density lipoprotein |
| MAG | monoacylglycerol |
| MAGL | monoacylglycerol lipase |
| NAcS | nucleus accumbens |
| PVN | paraventricular nucleus |
| T2D | type 2 diabetes mellitus |
| TG | triglyceride |
| THC | tetrahydrocannabinol |
| VMH | ventromedial hypothalamus |
| VTA | ventral tegmental area |
| WT | wild type |